Rezafungin
In Stock•Starting at $1132 for 100 mg•Purity ≥ 95%
| CAS No. | 1396640-59-7 |
|---|---|
| MDL No. | N/A |
| MF | C63H85N8O17+ |
| MW | 1226.40 |
| InChI Key | LNFCWEXGZIEGJW-TXSVMFMRSA-O |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 100 mg | 95% | $1132 | In Stock | |
| 250 mg | 95% | $1884 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Rezafungin is an echinocandin that inhibits 1,3-beta-D-glucan synthase. Developed by Cidara Therapeutics, it is approved for treating candidaemia and invasive candidiasis in adults aged >= 18 years with limited or no alternative treatment options. It is classified as an antibiotic antifungal drug, a quaternary ammonium ion, an azamacrocycle, a homodetic cyclic peptide, and an aromatic ether.
| CAS No. | 1396640-59-7 |
|---|---|
| Product Name | Rezafungin |
Associated Conditions
Candidemia·Sepsis·candidiasis·Candidiasis, Invasive·pneumocystosis·
* The information provided here is compiled from public sources and is for reference only.
